Edesa Biotech raises $10M in registered direct offering at $3.65/share

Edesa Biotech, Inc.

Gross proceeds of $10.0M from sale of 2,739,727 common shares or equivalents at $3.65/share.
Concurrent private placement of warrants to purchase 2,739,727 shares at $3.52, exercisable immediately for 5.5 years.
Offering expected to close March 24, 2022; net proceeds for working capital and general corporate purposes.
Terminated equity distribution agreement with RBC Capital Markets; $2.94M raised under that agreement through termination.
H.C. Wainwright acted as exclusive placement agent with 7% cash fee and 191,780 placement agent warrants.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.